Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Sanofi Looks To Climb Consumer Ladder In Boehringer Business Swap

This article was originally published in The Tan Sheet

Executive Summary

A pending agreement includes a $5.2bn cash payment from Boehringer to Sanofi but excludes Boehringer’s consumer product business in China. The brands Sanofi will add to its consumer health lineup include two marketed in the US, Dulcolax constipation relief and Zantac heartburn remedy.

Advertisement

Related Content

Deal Watch: Merck Hopes Moderna's Personalized Vaccines Can Increase Keytruda Patient Base
Sanofi Adds Consumer Brands, Grows Footprint With Boehringer Ingelheim Deal
Industry Roundup: Zantac 150 Choices, Nature's Health Warning
Sanofi Board Forces Out CEO Chris Viehbacher Amid Lantus Woes
Sanofi’s Nasacort First-In-Class Switch Receives FDA Approval
With $1.9 Bil. Bid For Chattem, Sanofi Knocks On Door To U.S. OTC Market

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS108088

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel